Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Visual outcome following optic neuritis: A 5-year review.
When does multiple sclerosis start? Three case reports and a review of the literature.
Mouse CD11b+Gr-1+ Myeloid Cells Can Promote Th17 Cell Differentiation and Experimental Autoimmune Encephalomyelitis.
Seasonal vitamin D changes and the impact on health risk assessment.
Autologous bone marrow transplantation for the treatment of multiple sclerosis.
Th17-biased RORγt transgenic mice become susceptible to a viral model for multiple sclerosis.
The effectiveness of aerobic training, cognitive behavioural therapy, and energy conservation management in treating MS-related fatigue: the design of the TREFAMS-ACE programme.
Cellular targets and mechanistic strategies of remyelination-promoting IgMs as part of the naturally occurring autoantibody repertoire.
Early P2X7R-related astrogliosis in autoimmune encephalomyelitis.
Oligoclonal band status in scandinavian multiple sclerosis patients is associated with specific genetic risk alleles.
Developmental maturation of innate immune cell function correlates with susceptibility to central nervous system autoimmunity.
Dual Targeting of the Chemokine Receptors CXCR4 and ACKR3 with Novel Engineered Chemokines.
Exercise and cognition in multiple sclerosis: The importance of acute exercise for developing better interventions.
Fulminant Demyelinating Diseases of the Central Nervous System.
Myeloradicular Form of Neuroschistosomiasis in a Six-Year-Old Boy Infected With Schistosoma mansoni.
Acute optic neuritis: Unmet clinical needs and model for new therapies.
Spin echo transverse relaxation and atrophy in multiple sclerosis deep gray matter: A two-year longitudinal study.
Localized atrophy of the thalamus and slowed cognitive processing speed in MS patients.
Status migrainosus as an initial presentation of multiple sclerosis.
Predictive value of different conventional and non-conventional MRI-parameters for specific domains of cognitive function in multiple sclerosis.
The effects of video-game training on broad cognitive transfer in multiple sclerosis: A pilot randomized controlled trial.
Central nervous system inflammatory demyelinating disorders among Hong Kong Chinese.
Protein kinase C polymorphisms and vitamin D levels in multiple sclerosis.
Opexa Therapeutics reports third quarter 2013 financial results and provides corporate update
New immunological approaches in treating and diagnosing CNS diseases.
Pages
« first
‹ previous
…
422
423
424
425
426
427
428
429
430
…
next ›
last »